Insider Transactions in Q1 2024 at Ambac Financial Group Inc (AMBC)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 08
2024
|
Claude Le Blanc Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,193
-0.24%
|
$17,895
$15.38 P/Share
|
|
Mar 08
2024
|
Claude Le Blanc Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,193
+0.24%
|
-
|
|
Mar 08
2024
|
David Trick Exec VP, CFO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
270
-0.18%
|
$4,050
$15.38 P/Share
|
|
Mar 08
2024
|
David Trick Exec VP, CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
270
+0.18%
|
-
|
|
Mar 08
2024
|
R Sharon Smith Exec VP & Chief Strategy Offr |
SELL
Payment of exercise price or tax liability
|
Direct |
233
-0.32%
|
$3,495
$15.38 P/Share
|
|
Mar 08
2024
|
R Sharon Smith Exec VP & Chief Strategy Offr |
BUY
Exercise of conversion of derivative security
|
Direct |
233
+0.31%
|
-
|
|
Mar 08
2024
|
Robert Bryan Eisman Sr. MD & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
87
-0.13%
|
$1,305
$15.38 P/Share
|
|
Mar 08
2024
|
Robert Bryan Eisman Sr. MD & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
87
+0.13%
|
-
|
|
Mar 08
2024
|
David Barranco Senior Managing Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,523
-2.21%
|
$37,845
$15.38 P/Share
|
|
Mar 08
2024
|
David Barranco Senior Managing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
7,001
+5.77%
|
-
|
|
Mar 08
2024
|
Stephen Michael Ksenak Sr. MD & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
218
-0.19%
|
$3,270
$15.38 P/Share
|
|
Mar 08
2024
|
Stephen Michael Ksenak Sr. MD & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
218
+0.19%
|
-
|
|
Mar 03
2024
|
Claude Le Blanc Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
888
-0.18%
|
$14,208
$16.19 P/Share
|
|
Mar 03
2024
|
Claude Le Blanc Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
888
+0.18%
|
-
|
|
Mar 03
2024
|
R Sharon Smith Exec VP & Chief Strategy Offr |
SELL
Payment of exercise price or tax liability
|
Direct |
179
-0.24%
|
$2,864
$16.19 P/Share
|
|
Mar 03
2024
|
R Sharon Smith Exec VP & Chief Strategy Offr |
BUY
Exercise of conversion of derivative security
|
Direct |
179
+0.24%
|
-
|
|
Mar 03
2024
|
Stephen Michael Ksenak Sr. MD & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
163
-0.15%
|
$2,608
$16.19 P/Share
|
|
Mar 03
2024
|
Stephen Michael Ksenak Sr. MD & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
163
+0.15%
|
-
|
|
Mar 03
2024
|
David Trick Exec VP, CFO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
201
-0.13%
|
$3,216
$16.19 P/Share
|
|
Mar 03
2024
|
David Trick Exec VP, CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
201
+0.13%
|
-
|
|
Mar 03
2024
|
David Barranco Senior Managing Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,880
-1.72%
|
$30,080
$16.19 P/Share
|
|
Mar 03
2024
|
David Barranco Senior Managing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,215
+4.56%
|
-
|
|
Mar 03
2024
|
Daniel Mc Ginnis Sr. MD & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
92
-1.09%
|
$1,472
$16.19 P/Share
|
|
Mar 03
2024
|
Daniel Mc Ginnis Sr. MD & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
92
+1.08%
|
-
|
|
Mar 03
2024
|
Robert Bryan Eisman Sr. MD & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
65
-0.1%
|
$1,040
$16.19 P/Share
|
|
Mar 03
2024
|
Robert Bryan Eisman Sr. MD & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
65
+0.1%
|
-
|
|
Feb 28
2024
|
David Trick Exec VP, CFO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
220
-0.14%
|
$3,520
$16.94 P/Share
|
|
Feb 28
2024
|
David Trick Exec VP, CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
220
+0.14%
|
-
|
|
Feb 28
2024
|
Claude Le Blanc Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
975
-0.19%
|
$15,600
$16.94 P/Share
|
|
Feb 28
2024
|
Claude Le Blanc Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
975
+0.19%
|
-
|
|
Feb 28
2024
|
Daniel Mc Ginnis Sr. MD & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,928
-15.62%
|
$46,848
$16.94 P/Share
|
|
Feb 28
2024
|
Daniel Mc Ginnis Sr. MD & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
7,072
+22.57%
|
-
|
|
Feb 28
2024
|
Robert Bryan Eisman Sr. MD & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
71
-0.1%
|
$1,136
$16.94 P/Share
|
|
Feb 28
2024
|
Robert Bryan Eisman Sr. MD & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
71
+0.1%
|
-
|
|
Feb 28
2024
|
David Barranco Senior Managing Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,063
-1.95%
|
$33,008
$16.94 P/Share
|
|
Feb 28
2024
|
David Barranco Senior Managing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,723
+5.12%
|
-
|
|
Feb 28
2024
|
Stephen Michael Ksenak Sr. MD & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
178
-0.16%
|
$2,848
$16.94 P/Share
|
|
Feb 28
2024
|
Stephen Michael Ksenak Sr. MD & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
178
+0.16%
|
-
|
|
Feb 28
2024
|
R Sharon Smith Exec VP & Chief Strategy Offr |
SELL
Payment of exercise price or tax liability
|
Direct |
196
-0.27%
|
$3,136
$16.94 P/Share
|
|
Feb 28
2024
|
R Sharon Smith Exec VP & Chief Strategy Offr |
BUY
Exercise of conversion of derivative security
|
Direct |
196
+0.26%
|
-
|
|
Feb 21
2024
|
David Barranco Senior Managing Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,143
-2.09%
|
$34,288
$16.25 P/Share
|
|
Feb 21
2024
|
David Barranco Senior Managing Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,143
+2.05%
|
-
|
|
Feb 21
2024
|
David Trick Exec VP, CFO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,101
-1.36%
|
$33,616
$16.25 P/Share
|
|
Feb 21
2024
|
David Trick Exec VP, CFO & Treasurer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,101
+1.34%
|
-
|
|
Feb 21
2024
|
Stephen Michael Ksenak Sr. MD & General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
1,861
-1.64%
|
$29,776
$16.25 P/Share
|
|
Feb 21
2024
|
Stephen Michael Ksenak Sr. MD & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,861
+1.61%
|
-
|
|
Feb 21
2024
|
Robert Bryan Eisman Sr. MD & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,041
-1.52%
|
$16,656
$16.25 P/Share
|
|
Feb 21
2024
|
Robert Bryan Eisman Sr. MD & CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,041
+1.49%
|
-
|
|
Feb 21
2024
|
Claude Le Blanc Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,257
-1.62%
|
$132,112
$16.25 P/Share
|
|
Feb 21
2024
|
Claude Le Blanc Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,257
+1.59%
|
-
|